Company & Sponsor Intelligence
Maastricht University Medical Center
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials8
Recruiting1
Completed7
Countries1
Therapeutic footprint
dementia_otherepilepsyother_neurologyother_psychiatrypain_neuropathyparkinsonsstroke
Indexed studies
NCT04657588Controlling Faecal Incontinence With a Novel Anal Device: a Cost-effectiveness Trial
other_psychiatry · NetherlandsNA
other_psychiatry · NetherlandsNA
NCT01335425The Rolandic Epilepsy/ESES/Landau-Kleffner Syndrome and Correlation With Language Impairment Study
epilepsy · NetherlandsCOMPLETED
epilepsy · NetherlandsCOMPLETED
NCT04918745VertiGO! - Get up and GO! With the Vestibular Implant
other_neurology · NetherlandsNA
other_neurology · NetherlandsNA
NCT02585349Cognition and Affect After Stroke: a Prospective Evaluation of Risks
stroke · NetherlandsCOMPLETED
stroke · NetherlandsCOMPLETED
NCT04093908Prediction of STN DBS Motor Response in PD
parkinsons · NetherlandsCOMPLETED
parkinsons · NetherlandsCOMPLETED
NCT00846950Effects of H1-Antagonist on Cognition
other_neurology · NetherlandsNA
other_neurology · NetherlandsNA
NCT01433666Roflumilast and Cognition
dementia_other · NetherlandsPHASE2
dementia_other · NetherlandsPHASE2
NCT02551029fMRI and Visceral Perception Upon Capsaicin Infusion
pain_neuropathy · NetherlandsNA
pain_neuropathy · NetherlandsNA
Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →